Corneal injuries, a leading cause of visual impairment, are traditionally addressed through tissue transplantation. However, challenges such as donor shortages, graft rejection, and complications from suturing often limit their effectiveness. Current corneal adhesives frequently fall short in both adhesion strength and biocompatibility. We present an innovative solution: a photocurable hydrogel that integrates dopamine-conjugated methacrylated silk fibroin (d-MSF) with a decellularized corneal matrix (DCM). This hydrogel combines advanced materials to create a bioadhesive system that offers superior adhesion inspired by mussel adhesion and mimics the native tissue environment. FTIR and NMR analyses confirm that our conjugation process prevents unwanted beta-sheet aggregation, ensuring both stability and transparency. The hydrogel demonstrates excellent rheological properties, including enhanced shear-thinning and impressive shear and creep recovery, making it highly suitable for extrusion-based bioprinting. We successfully bioprinted a bilayer corneal patch, featuring a concentric ring of d-MSF as the first layer, overlaid with a second layer of DCM. The implants exhibit strong tissue adhesion, with an adhesion strength of 85 ± 5.6 KPa, and Young's modulus of 0.48 ± 0.064 MPa, ensuring excellent structural integrity. This results in a highly transparent (>80 %) and functional adhesive corneal patch. This advancement offers a promising, biocompatible alternative to traditional keratoprostheses, advancing corneal repair technology.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijbiomac.2025.141761 | DOI Listing |
ACS Appl Mater Interfaces
March 2025
Department of Chemistry and Biochemistry, Ohio University, 133 University Terrace, Chemistry Building, Athens, Ohio 45701, United States.
Keratoprosthesis is an alternative treatment for visual impairment caused by corneal diseases. However, due to the recognized postoperative complications in available Kpros, there is an exigency to explore potential alternative skirt materials for corneal implants. This study aims to investigate the suitability of poly(2-methoxyethyl methacrylate--2-hydroxyethyl methacrylate) (15% MEMA: 85% HEMA), and poly(2-phenoxyethyl methacrylate--2-hydroxyethyl methacrylate) (15% PhEMA: 85% HEMA) copolymers as a corneal implant material by evaluating their ability to adhere human keratocytes.
View Article and Find Full Text PDFFront Med (Lausanne)
February 2025
Biogipuzkoa Health Research Institute, Donostia-San Sebastián, Spain.
Background/aims: Chemical burns to the eye cause extensive ocular surface damage, often resulting in permanent visual impairment. The amniotic membrane (AM), with its regenerative properties, has shown great potential in treating such injuries. Recent innovations, including hydrogel-based delivery systems, have been developed to improve drug retention and promote corneal healing.
View Article and Find Full Text PDFExp Eye Res
March 2025
Instituto Universitario Fernández-Vega (IUFV), Fundación de Investigación Oftalmológica, University of Oviedo, 33012, Oviedo, Spain; Department of Functional Biology, University of Oviedo, 33006, Oviedo, Spain; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011, Oviedo, Spain. Electronic address:
The yeast form of Candida albicans uses glycosaminoglycans (GAGs), primarily heparan sulfate, as adhesion receptors for corneal epithelial cells. However, during the transition to the hyphal form, the fungus shifts to using alternative receptors. This study aims to identify fungal adhesins involved in GAG binding and examine their expression dynamics during tissue adhesion.
View Article and Find Full Text PDFSci Rep
March 2025
Research, Development and Innovation Department (R&D+i Department), Faes Farma, Av. Autonomía 10, Bizkaia, 48940, Spain.
Bilastine is a non-sedating, highly selective H1-antihistamine with proven efficacy and safety in treating allergic rhinoconjunctivitis and urticaria in adults and children. Allergic conjunctivitis, a common ocular condition, negatively impacts quality of life. Topical eye drops are the standard treatment, though ocular bioavailability is often low.
View Article and Find Full Text PDFSci Adv
March 2025
Department of Ophthalmology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200011, China.
Topical drug delivery on ocular surface always suffers from frequent administration and low bioavailability due to short drug residence. Despite advances of different adhesive ophthalmic drugs in extending release, cornea and eyelid nonselective adhesion inevitably causes ocular discomfort and even damage. Here, we describe in situ formation of an adhesive lubricative Janus nanocoating (ALJN) to enable long-lasting comfort drug delivery.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!